A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.
The biotechnology company Encellin acquired exclusive worldwide rights to the technology, originally developed in the laboratory of Tejal Desai,...
Ana Cruz knew, when she was very young, exactly what she wanted to do when she grew up, she told the UCSF doctor of pharmacy (PharmD) Class of 2021 at their White Coat ceremony.
She wanted the same job as the woman in white.
Now, Cruz is a PharmD student in the Class of 2018, and was the student speaker at the event, held Friday...
For the UCSF doctor of pharmacy (PharmD) Class of 2021, October 13 was the day they officially entered the profession. In a ceremony on the Parnassus campus, each student donned a white coat, a symbol of health care professionals for more than 100 years.
“Today marks your transition from lay person to full-fledged professional,” Dean B...
Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.
Wired magazine’s Megan Molteni visited Shuvo Roy, PhD, to check in on...
Somewhere between the pleasant September evening in San Francisco, the lively conversation about the profession of pharmacy, and the excellent wine, there were potential long-term professional connections in the making.
Solid mentorships can catalyze amazing careers, but mentors are also hard to find, let alone develop. For the doctor...
The newest UCSF doctor of pharmacy (PharmD) class gathered for the first time on Wednesday, September 20, in San Francisco’s foggy Golden Gate Park. Although it was their first time meeting in person, class members have been getting to know each other online for months.
The Class of 2021 spent the week in orientation, learning about...
Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX). ISSX is an international association of scientists that promotes the understanding of the interactions of medicines and...
The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine....